{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:34:03Z","timestamp":1780428843920,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s40121-022-00596-x","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T18:08:38Z","timestamp":1643911718000},"page":"757-770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3044-1117","authenticated-orcid":false,"given":"Iris","family":"De Ryck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanna","family":"Sarakinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Nakakana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Luna","family":"Cilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustin","family":"Ndiaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venanzio","family":"Vella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Auerbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Paolo","family":"Granada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audino","family":"Podda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"596_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S1473-3099(18)30362-1","volume":"18","author":"GBD 2016 Diarrhoeal Disease Collaborators","year":"2018","unstructured":"GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18:1211\u201328. https:\/\/doi.org\/10.1016\/S1473-3099(18)30362-1.","journal-title":"Lancet Infect Dis"},{"key":"596_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/s0140-6736(17)33296-8","volume":"391","author":"KL Kotloff","year":"2018","unstructured":"Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AKM. Shigellosis. Lancet. 2018;391:801\u201312. https:\/\/doi.org\/10.1016\/s0140-6736(17)33296-8.","journal-title":"Lancet"},{"key":"596_CR3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1473-3099(20)30488-6","volume":"21","author":"D Cohen","year":"2021","unstructured":"Cohen D, Atsmon J, Artaud C, Meron-Sudai S, Gougeon M-L, Bialik A, et al. Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study. Lancet Infect Dis. 2021;21:546\u201358. https:\/\/doi.org\/10.1016\/S1473-3099(20)30488-6.","journal-title":"Lancet Infect Dis"},{"key":"596_CR4","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1016\/j.vaccine.2018.06.063","volume":"36","author":"RW Frenck Jr","year":"2018","unstructured":"Frenck RW Jr, Baqar S, Alexander W, Dickey M, McNeal M, El-Khorazaty J, et al. A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei. Vaccine. 2018;36:4880\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.063.","journal-title":"Vaccine"},{"key":"596_CR5","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1128\/cvi.00224-16","volume":"23","author":"MS Riddle","year":"2016","unstructured":"Riddle MS, Kaminski RW, Di Paolo C, Porter CK, Gutierrez RL, Clarkson KA, et al. Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella flexneri 2a administered to healthy adults: a single-blind, randomized phase I study. Clin Vaccine Immunol. 2016;23:908\u201317. https:\/\/doi.org\/10.1128\/cvi.00224-16.","journal-title":"Clin Vaccine Immunol"},{"key":"596_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1021\/acs.bioconjchem.5b00617","volume":"27","author":"RMF van der Put","year":"2016","unstructured":"van der Put RMF, Kim TH, Guerreiro C, Thouron F, Hoogerhout P, Sansonetti PJ, et al. A synthetic carbohydrate conjugate vaccine candidate against shigellosis: improved bioconjugation and impact of alum on immunogenicity. Bioconjug Chem. 2016;27:883\u201392. https:\/\/doi.org\/10.1021\/acs.bioconjchem.5b00617.","journal-title":"Bioconjug Chem"},{"key":"596_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/biot.201800376","volume":"14","author":"Z Kis","year":"2019","unstructured":"Kis Z, Shattock R, Shah N, Kontoravdi C. Emerging technologies for low-cost, rapid vaccine manufacture. Biotechnol J. 2019;14: e1800376. https:\/\/doi.org\/10.1002\/biot.201800376.","journal-title":"Biotechnol J"},{"key":"596_CR8","first-page":"153","volume":"78","author":"M Scholtz","year":"2000","unstructured":"Scholtz M, Duclos P. Immunization safety: a global priority. Bull World Health Organ. 2000;78:153\u20134.","journal-title":"Bull World Health Organ"},{"key":"596_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157385","volume":"11","author":"V Muturi-Kioi","year":"2016","unstructured":"Muturi-Kioi V, Lewis D, Launay O, Leroux-Roels G, Anemona A, Loulergue P, et al. Neutropenia as an adverse event following vaccination: results from randomized clinical trials in healthy adults and systematic review. PLoS ONE. 2016;11: e0157385. https:\/\/doi.org\/10.1371\/journal.pone.0157385.","journal-title":"PLoS ONE"},{"key":"596_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12878-016-0054-8","volume":"16","author":"S Denic","year":"2016","unstructured":"Denic S, Narchi H, Al Mekaini LA, Al-Hammadi S, Al Jabri ON, Souid AK. Prevalence of neutropenia in children by nationality. BMC Hematol. 2016;16:15. https:\/\/doi.org\/10.1186\/s12878-016-0054-8.","journal-title":"BMC Hematol"},{"key":"596_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/vaccines8030540","volume":"8","author":"F Micoli","year":"2020","unstructured":"Micoli F, Alfini R, Di Benedetto R, Necchi F, Schiavo F, Mancini F, et al. GMMA Is a versatile platform to design effective multivalent combination vaccines. Vaccines (Basel). 2020;8:540. https:\/\/doi.org\/10.3390\/vaccines8030540.","journal-title":"Vaccines (Basel)"},{"key":"596_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ebiom.2017.07.013","volume":"22","author":"O Launay","year":"2017","unstructured":"Launay O, Lewis DJM, Anemona A, Loulergue P, Leahy J, Scir\u00e9 AS, et al. Safety profile and immunologic responses of a novel vaccine against Shigella sonnei administered intramuscularly, intradermally and intranasally: results from two parallel randomized phase 1 clinical studies in healthy adult volunteers in Europe. EBioMedicine. 2017;22:164\u201372. https:\/\/doi.org\/10.1016\/j.ebiom.2017.07.013.","journal-title":"EBioMedicine"},{"key":"596_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fimmu.2019.00335","volume":"10","author":"O Launay","year":"2019","unstructured":"Launay O, Ndiaye AGW, Conti V, Loulergue P, Scire AS, Landre AM, et al. Booster vaccination with GVGH Shigella sonnei 1790GAHB GMMA vaccine compared to single vaccination in unvaccinated healthy European adults: results from a phase 1 clinical trial. Front Immunol. 2019;10:335. https:\/\/doi.org\/10.3389\/fimmu.2019.00335.","journal-title":"Front Immunol"},{"key":"596_CR14","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.3389\/fimmu.2017.01884","volume":"8","author":"CW Obiero","year":"2017","unstructured":"Obiero CW, Ndiaye AGW, Scir\u00e9 AS, Kaunyangi BM, Marchetti E, Gone AM, et al. A phase 2a randomized study to evaluate the safety and immunogenicity of the 1790GAHB generalized modules for membrane antigen vaccine against Shigella sonnei administered intramuscularly to adults from a shigellosis-endemic country. Front Immunol. 2017;8:1884. https:\/\/doi.org\/10.3389\/fimmu.2017.01884.","journal-title":"Front Immunol"},{"key":"596_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101076","volume":"39","author":"RW Frenck","year":"2021","unstructured":"Frenck RW, Conti V, Ferruzzi P, Ndiaye AGW, Parker S, McNeal MM, et al. Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: results from a phase 2b randomized, placebo-controlled challenge study in adults. EClinicalMedicine. 2021;39: 101076. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101076.","journal-title":"EClinicalMedicine"},{"key":"596_CR16","unstructured":"US Food and Drug Administration Guidance for industry: toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. 2007 https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/toxicity-grading-scale-healthy-adult-and-adolescent-volunteers-enrolled-preventive-vaccine-clinical. Accessed 18 Aug 2021."},{"key":"596_CR17","unstructured":"US Department of Health and Human Services NIoH, National Institute of Allergy and Infectious Diseases, Division of AIDS, Division of AIDS (DAIDS) Table for grading the severity of adult and pediatric adverse events, Corrected Version 2.1. 2017 https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/daidsgradingcorrectedv21.pdf. Accessed 18 Aug 2021."},{"key":"596_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004401","volume":"4","author":"E Karita","year":"2009","unstructured":"Karita E, Ketter N, Price MA, Kayitenkore K, Kaleebu P, Nanvubya A, et al. CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa. PLoS ONE. 2009;4: e4401. https:\/\/doi.org\/10.1371\/journal.pone.0004401.","journal-title":"PLoS ONE"},{"key":"596_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ympdx.2019.100005","volume":"1","author":"A Koen","year":"2019","unstructured":"Koen A, Jose L, Madhi SA, Fix A, Cryz S, Groome MJ. Neutrophil counts in healthy South African infants: implications for enrollment and adverse event grading in clinical trials in an African setting. J Pediatr X. 2019;1: 100005. https:\/\/doi.org\/10.1016\/j.ympdx.2019.100005.","journal-title":"J Pediatr X"}],"updated-by":[{"DOI":"10.1007\/s40121-022-00634-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000}}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00596-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-022-00596-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00596-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T13:04:09Z","timestamp":1650373449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-022-00596-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1007\/s40121-022-00596-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40121-022-00634-8","asserted-by":"object"}]},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]},"assertion":[{"value":"26 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40121-022-00634-8","URL":"https:\/\/doi.org\/10.1007\/s40121-022-00634-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}